About 700 reports

  • Untitled
  • United States Sterile Injectables Market, By Indication

Monoclonal Antibody Insulin Vaccines Fusion Proteins Immunoglobulins Others ##. ##% ##. ##% ##. ##% ##. ##% ##. ##% Source: Azoth Analytics Estimates Global Monoclonal Antibody Sterile Injectables Market Market Size, By Value, 2013-2017 (USD Billion) Figure ##: Global

  • Chronic Disease
  • World
  • Market Size
  • Baxter International Inc.
  • Gilead Sciences, Inc.
  • CARDIOVASCULAR DISEASE DRUGS, GLOBAL, CLINICAL TRIAL DURATION BY STAGE OF DEVELOPMENT AND MOLECULE TYPE (MONTHS), 2006-2017
  • C) Phase III

Sanofi' s Praluent, a PCSK## inhibitor, was also approved in 2015 and is a monoclonal antibody (mAb) antidyslipidemic with high revenue potential.

  • Chronic Disease
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Pfizer Inc.
  • BRONCHODILATORS MARKET IN APAC

Xolair was the only monoclonal antibody approved for the treatment of allergic asthma in APAC, until the approval of GlaxoSmithKline' s mepolizumab in early 2016.

  • Chronic Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Drug Pipeline for Peanut Allergy

Table ##. ##: Drug Pipeline for Peanut Allergy Epicutaneus Immunotherapy DBV technologies Viaskin Peanut* Oral immunotherapy Aimmune Therapeutics AR-## Prota PPOIT Camallergy CA-## Injectable Immunotherapy Astellas ASP-## HAL Allergy HAlMPE-## Aravax PVX-## Sublingual Immunotherapy Sanofi

  • Chronic Disease
  • Respiratory Disease
  • World
  • Merck & Co., Inc.
  • Stallergenes Greer plc

It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal

  • Chronic Disease
  • World
  • Amgen Inc.
  • Antares Pharma, Inc.
  • Bayer AG

Anti-Procollagen type I C-terminal propeptide (human, PICP) Mouse monoclonal antibody ##.

  • Chronic Disease
  • North America
  • World
  • Abbott Laboratories, Inc.
  • Danaher Corporation
  • RESPIRATORY DISORDERS THERAPEUTICS MARKET, GLOBAL, REGENERON ANNUAL REVENUE
  • RESPIRATORY DISORDERS THERAPEUTICS MARKET, GLOBAL, ROCHE ANNUAL REVENUE FORECAST

THESE TWO THERAPIES ARE MONOCLONAL ANTIBODY (MAB) PRODUCTS THAT TARGET INTERLEUKIN RECEPTORS, AND TYPIFY THE GROWING PROMINENCE OF MABS IN THE TREATMENT OF RESPIRATORY DISEASES.

  • Chronic Disease
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Biologics, Inc.
  • shows the global sales of osteoporosis branded products by company over the forecast period, 2017-2027.
  • Global Sales of Branded Osteoporosis Products, by Company, 2017-2027

Amgen' s Prolia (denosumab) is a fully-human monoclonal antibody (mAb) indicated for the treatment of postmenopausal osteoporosis and as a treatment to increase bone mass in men with osteoporosis.

  • Chronic Disease
  • United States
  • World
  • Amgen Inc.
  • Eli Lilly & Co.

Global Asthma & COPD Therapies Market 2017-2027 ##.

  • Chronic Disease
  • Therapy
  • World
  • Market Shares
  • Market Size
  • Osteoporosis Therapeutics Market, Global, Co-development Deals by Molecule
  • Osteoporosis Therapeutics Market, Global, All Pipeline Products, Preclinical, 2017

Small molecules, antibodies, recombinant peptides, synthetic peptides and mAbs involved one deal each.

  • Chronic Disease
  • Musculoskeletal Disorder
  • Therapy
  • Market Size
  • Amgen Inc.

Gene Therapy in CVMD

7012 7995 6236

THE CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) OVERSEES CHEMICAL-BASED DRUGS AS WELL AS MONOCLONAL ANTIBODIES AND CYTOKINES Source: Balani, 2018; Ecorys and University of Utrecht, 2016; Halioua-Haubold et al., 2017 FDA The Center for Drug Evaluation and Research (CDER) oversees

  • Chronic Disease
  • United States
  • AnGes MG, Inc.
  • Juventas Therapeutics, Inc.
  • ViroMed Co., Ltd.
  • 8 Appendix

HL-## is a fully human monoclonal antibody targeting IgG Receptor FcRn Large Subunit p##.

  • Chronic Disease
  • Immunotherapy
  • Therapy
  • United States
  • World
  • PERSONALIZED MEDICINE FOR TREATMENT OF CARDIOVASCULAR DISORDERS
  • SANOFI

The company is also carrying out trials for Praluent®, a biopharmaceutical anti-cholesterol drug (a human monoclonal antibody) used to treat high cholesterol in adults whose cholesterol is not controlled by diet and statin treatment.

  • Chronic Disease
  • World
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • DIABETES DRUGS MARKET, GLOBAL, ALL PIPELINE PRODUCTS, 2017 (PART 6)
  • DIABETES DRUGS MARKET, GLOBAL, ALL PIPELINE PRODUCTS, 2017 (PART 9)

This promotes an inflammatory response in the islets of Langerhans (insulitis), and also triggers a humoral response whereby antibodies to B-cell antigens are produced - including islet cell antibodies and specific antibodies to insulin, glutamic acid decarboxylase, and pr

  • Chronic Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Eli Lilly & Co.
  • Johnson & Johnson
  • HEART FAILURE THERAPEUTICS MARKET, GLOBAL, ALL PIPELINE PRODUCTS, DISCOVERY, 2018
  • 9 Appendix

STEM CELL REPORTS; ##(##): ##-## ##(##): ##-## ##(##): ##-## IN CARDIOLOGY (JCARE-CARD).

  • Chronic Disease
  • Market Size
  • Bristol-Myers Squibb Company
  • Les Laboratoires Servier SAS
  • Novartis AG

The monoclonal or polyclonal antibody specific for the preferred analyte is pre-coated onto a PVDF-backed microplate.

  • Chronic Disease
  • World
  • Forecast
  • Market Size
  • bioMerieux S.A.

IT IS USED TO PERFORM CELLULAR ANALYSIS OF ALLERGY AND CONSISTS OF AN OPTIMIZED THREE-COLOR COMBINATION OF FLUORESCENT MONOCLONAL ANTIBODIES, ACTIVATION SOLUTION, AND POSITIVE CONTROL FOR IGE MEDIATED BASOPHIL ACTIVATION.

  • Chronic Disease
  • Hospital
  • Danaher Corporation
  • Hitachi, Ltd.
  • Thermo Fisher Scientific, Inc.

Also, the report:& nbsp; & nbsp; & nbsp; & nbsp; -& nbsp; Examines market applications of Molecular Diagnostics, & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; Monoclonal Antibodies, Immunoassays, IT and other emerging

  • Chronic Disease
  • Europe
  • Japan
  • United States
  • Demand

& nbsp; Also, the report:& nbsp; & nbsp; & nbsp; & nbsp; -& nbsp; Examines market applications of Molecular Diagnostics, & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; Monoclonal Antibodies, Immunoassays, IT and oth

  • Chronic Disease
  • Medical Biotechnology
  • Europe
  • World
  • Demand

Moerover, in May 2019, Mitsubishi Tanabe Pharma Corporation (MTPC) introduced SIMPONI Subcutaneous injection ## mg autoinjector, a human TNF-alpha monoclonal antibody in Japan.

  • Chronic Disease
  • Diabetes
  • Forecast
  • Market Size
  • Amgen Inc.

Also, the report:& nbsp; & nbsp; & nbsp; & nbsp; -& nbsp; Examines market applications of Molecular Diagnostics, & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; Monoclonal Antibodies, Immunoassays, IT and other emerging

  • Chronic Disease
  • Europe
  • Japan
  • United States
  • Demand

Also, the report:& nbsp; & nbsp; & nbsp; & nbsp; -& nbsp; Examines market applications of Molecular Diagnostics, & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; Monoclonal Antibodies, Immunoassays, IT and other emerging

  • Chronic Disease
  • Europe
  • Japan
  • United States
  • Demand

Simulect® (basiliximab) is a chimeric (murine/ human) monoclonal antibody Zortress/ Certican (everolimus) is an oral inhibitor of the mTOR pathway.

  • Chronic Disease
  • North America
  • World
  • Market Size
  • Pfizer Inc.

The company provides biosimilars comprising recombinant human insulin, insulin glargine, insulin lispro, insulin aspart, and monoclonal antibodies and other biologics.

  • Chronic Disease
  • World
  • Forecast
  • Market Size
  • Novo Nordisk Group

BD Life Sciences involve in the production of research and clinical tools that facilitate the study of cells, for instance company fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for Moreover, company i

  • Cell Therapy
  • Chronic Disease
  • North America
  • World
  • Becton Property Group

Also, the report:& nbsp; & nbsp; & nbsp; & nbsp; -& nbsp; Examines market applications of Molecular Diagnostics, & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; Monoclonal Antibodies, Immunoassays, IT and other emerging

  • Chronic Disease
  • Medical Biotechnology
  • Europe
  • World
  • Demand
  • INNOVATIVE EARLY-STAGE APPROACHES FOR PEANUT ALLERGY, 2017

THESE INCLUDE ANB-##, A PIPELINE ANTI-IL## MONOCLONAL ANTIBODY, AND DUPIXENT, AN ANTI-IL## MONOCLONAL ANTIBODY ALREADY MARKETED FOR AD.

  • Chronic Disease
  • Australia
  • World
  • Forecast
  • Aimmune Therapeutics, Inc.
  • 4.2 DRIVERS

For instance, in August 2018, Creative Diagnostics developed a set of humanized monoclonal antibodies (IgM, IgG or IgA) that can be used as calibrators, positive, negative, or quality controls in assay development and manufacturing of diagnostic kits.

  • Chronic Disease
  • Therapy
  • World
  • Forecast
  • Market Size

& nbsp; Also, the report:& nbsp; & nbsp; & nbsp; & nbsp; -& nbsp; Examines market applications of Molecular Diagnostics, & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; Monoclonal Antibodies, Immunoassays, IT and oth

  • Chronic Disease
  • Medical Biotechnology
  • Europe
  • World
  • Demand

& nbsp; Also, the report:& nbsp; & nbsp; & nbsp; & nbsp; -& nbsp; Examines market applications of Molecular Diagnostics, & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; Monoclonal Antibodies, Immunoassays, IT and oth

  • Chronic Disease
  • Pathology
  • Respiratory Disease
  • World
  • Demand